Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lindeman

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Breast Cancer Research and Treatment|October 15, 2013
Distinct nuclear receptor expression in stroma adjacent to breast tumorsKevin C Knower, Ashwini L Chand, Natalie Eriksson, et al.
Developmental Cell|December 8, 2018
Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from QuiescenceNai Yang Fu, Bhupinder Pal, Yunshun Chen, et al.
Nature Communications|March 23, 2025
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regenerationHui San Chin, Jinming Cheng, Shih Han Hsu, et al.
Blood Advances|December 15, 2022
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cellsCharis E Teh, Hongke Peng, Meng-Xiao Luo, et al.
The EMBO Journal|April 11, 2025
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesisRosa Pascual, Jinming Cheng, Amelia H De Smet, et al.
Nature Medicine|August 4, 2009
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriersElgene Lim, François Vaillant, Di Wu, et al.
International Journal of Cancer|August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusNiamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast CancerJames R Whittle, François Vaillant, Elliot Surgenor, et al.
Nature Cell Biology|January 12, 2024
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriersRachel Joyce, Rosa Pascual, Luuk Heitink, et al.
Science Translational Medicine|August 4, 2017
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancerDelphine Merino, James R Whittle, François Vaillant, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Breast Cancer Research and Treatment|October 15, 2013
Distinct nuclear receptor expression in stroma adjacent to breast tumorsKevin C Knower, Ashwini L Chand, Natalie Eriksson, et al.
Developmental Cell|December 8, 2018
Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from QuiescenceNai Yang Fu, Bhupinder Pal, Yunshun Chen, et al.
Nature Communications|March 23, 2025
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regenerationHui San Chin, Jinming Cheng, Shih Han Hsu, et al.
Blood Advances|December 15, 2022
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cellsCharis E Teh, Hongke Peng, Meng-Xiao Luo, et al.
The EMBO Journal|April 11, 2025
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesisRosa Pascual, Jinming Cheng, Amelia H De Smet, et al.
Nature Medicine|August 4, 2009
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriersElgene Lim, François Vaillant, Di Wu, et al.
International Journal of Cancer|August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusNiamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast CancerJames R Whittle, François Vaillant, Elliot Surgenor, et al.
Nature Cell Biology|January 12, 2024
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriersRachel Joyce, Rosa Pascual, Luuk Heitink, et al.
Science Translational Medicine|August 4, 2017
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancerDelphine Merino, James R Whittle, François Vaillant, et al.
Pageof 30